1231-C, 1233-C Antifungal Cream

Manufacturer
Dynarex Corporation
Effective date
2026-03-18
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:51:06

Label at a glance#

ProductAntifungal
Active ingredientCLOTRIMAZOLE
Label structure9 sections

Indications and uses

• For the treatment of most athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis) • Relieves itching, scaling, burning, redness, soreness, irritation, discomfort, and chafing associated with jock itch and itching, burning feet

Dosage and administration

• Clean the affected area and dry thoroughly. Apply a thin layer over affected area twice daily (morning and night) or as directed by a doctor. • Supervise children in the use of this product. • For athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily. • For athlete's foot and ringworm; use daily for 4 weeks. • If cond...

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Clotrimazole USP 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

• For the treatment of most athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis)

• Relieves itching, scaling, burning, redness, soreness, irritation, discomfort, and chafing associated with jock itch and itching, burning feet

Warnings

WARNINGS SECTION

• Do not use on children under 2 years of age unless directed by a doctor

• For external use only

• Avoid contact with eyes

Stop use and ask a doctor if

OTC - STOP USE SECTION

• Irritation occurs or if there is no improvement within 4 weeks, discontinue use and consult a doctor for athlete's foot and ringworm.

• Irritation occurs or if there is no improvement within 2 weeks, discontinue use and consult a doctor for jock itch.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away

Directions

DOSAGE & ADMINISTRATION SECTION

• Clean the affected area and dry thoroughly. Apply a thin layer over affected area twice daily (morning and night) or as directed by a doctor. • Supervise children in the use of this product. • For athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily. • For athlete's foot and ringworm; use daily for 4 weeks. • If condition persists longer, consult a doctor. • This product is not effective on the scalp or nails.

Other information

OTHER SAFETY INFORMATION

• Store at controlled room temperature 20°-25°C (68°-77°F)

• Tamper evident. Do not use if seal is damaged.

Inactive ingredients

INACTIVE INGREDIENT SECTION

ceteth-20, cetostearyl alcohol, light mineral oil, methylparaben, propylene glycol, propylparaben, purified water, petrolatum

Label 1231-C

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

1231-C_IN_MASTER1231-C_IN_MASTER

Label 1233-C

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

1233-C_IN_MASTER1233-C_IN_MASTER

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
309367clotrimazole 1 % Topical CreamPSN1
309367clotrimazole 10 MG/ML Topical CreamSCD1
309367clotrimazole 1 % Topical CreamSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CLOTRIMAZOLE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130840117346642GTIN-13: 0840117346642
EAN-13: 0840117346642
GTIN-12: 840117346642
UPC-A: 840117346642
GTIN storage (14 digits): 00840117346642
1231-C_IN_MASTER_R250917-5.jpg
BarcodeEAN-130840117346666GTIN-13: 0840117346666
EAN-13: 0840117346666
GTIN-12: 840117346666
UPC-A: 840117346666
GTIN storage (14 digits): 00840117346666
1233-C_IN_MASTER_R250917-6.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b64d2752-34ef-378a-1f4f-8bff32b0d1aeProduct name420250626
cb7783e0-feaa-7e56-fb3b-d43b6efa77c9Product name220250121
f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6Product name220151106
f5395dd2-4395-d8c6-3477-8c2d4a2f951cProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
67777-727-01Antifungal28.4 g in 1 TUBECREAM28.41
67777-727-02Antifungal72 in 1 CASECREAM721
67777-727-03Antifungal113 g in 1 TUBECREAM1131
67777-727-04Antifungal6 in 1 BOXCREAM61
67777-727-05Antifungal4 in 1 CASECREAM41

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
67777-72767777-727-01, 67777-727-02, 67777-727-03, 67777-727-04, 67777-727-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AntifungalCLOTRIMAZOLEDynarex Corporation4d4cc4b4-c0b4-9e25-e063-6294a90a70b82026-03-18WarningsExact identifier
ndc (package): 67777-727-02
ndc (package): 67777-727-04
ndc (package): 67777-727-05
ndc (package): 67777-727-03
ndc (package): 67777-727-01
ndc (product): 67777-727
ndc11 (package): 67777072701
ndc11 (package): 67777072702
ndc11 (package): 67777072703
ndc11 (package): 67777072705
ndc11 (package): 67777072704
spl id: 4d4cc4b4-c0b5-9e25-e063-6294a90a70b8
spl set id: 4d4cc4b4-c0b4-9e25-e063-6294a90a70b8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.